Meta Biomed Co., Ltd.
Financials
Valuation Metrics
Meta Biomed Co., Ltd.'s Market Cap is ₩997B. At end of 2025 it was ₩1350B. Ranked #1207 of 2,410 in KR market (top 50%), #647 of 1,631 on KOSDAQ (top 40%), #44 of 94 in Health Care Equipment & Services (top 47%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 99.72B KRW | KR#1,207/2,410 Sec#44/94 |
| Revenue | 101.19B KRW | KR#1,409/2,410 Sec#36/94 |
| Net Income | 16.70B KRW | KR#779/2,410 Sec#20/94 |
| Total Assets | 194.62B KRW | KR#1,335/2,410 Sec#36/94 |
| Net Assets | 130.38B KRW | KR#1,232/2,410 Sec#36/94 |
| Employees | 296 | KR#800/2,410 Sec#23/94 |
| Value | ||
| P/E | 5.97x | KR#521/2,410 Sec#10/94 |
| P/B | 0.76x | KR#1,298/2,410 Sec#31/94 |
| PEG | 0.02x | KR#199/2,410 Sec#8/94 |
| P/S | 0.99x | KR#1,443/2,410 Sec#28/94 |
| FCF Yield | -0.47% | KR—/2,410 Sec—/94 |
| Profitability | ||
| ROE | 12.81% | KR#423/2,410 Sec#17/94 |
| ROA | 8.58% | KR#385/2,410 Sec#22/94 |
| Op. Margin | 18.91% | KR#183/2,410 Sec#15/94 |
| Revenue Growth | 1.82% | KR#1,400/2,410 Sec#70/94 |
| Earnings Growth | 287.42% | KR#174/2,410 Sec#10/94 |
| Financial Health | ||
| Debt Ratio | 49.27% | KR#949/2,410 Sec#53/94 |
| FCF | -471.2M KRW | KR#1,248/2,410 Sec#36/94 |
| Cash | 15.31B KRW | KR#1,410/2,410 Sec#40/94 |
| Current Ratio | 1.53x | KR#1,170/2,410 Sec#64/94 |
| Dividend | ||
| Div. Yield | 2.89% | KR#729/2,410 Sec#15/94 |
| Div. Growth | 250.00% | KR#38/2,410 Sec#2/94 |
| Performance | ||
| 1Y Return | -34.70% | KR#1,581/2,410 Sec#50/94 |
| 1M Return | 0.14% | KR#316/2,410 Sec#10/94 |
| From 52W High | -42.20% | KR#822/2,410 Sec#32/94 |
| 1Y MDD | -45.58% | KR#762/2,410 Sec#26/94 |
| Trading | ||
| Volume | 24,020 shares | KR#794/2,410 Sec#29/94 |
| Trading Value | 87.0M KRW | KR#1,055/2,410 Sec#41/94 |
| Foreign Own. | 5.31% | KR#820/2,410 Sec#26/94 |
| Per Share | ||
| EPS | 615 KRW | KR#911/2,410 Sec#22/94 |
| BPS | 4,798 KRW | KR#1,541/2,410 Sec#39/94 |
Company Info
Meta Biomed, established in 1990 and listed on KOSDAQ in 2008, researches, develops, produces, and sells medical devices, including dental materials and suture raw threads. The company has secured a global network with two production and four sales bases, expanding into medical fields by utilizing biocompatible polymer materials. It aims to diversify its medical material business and stabilize its profit structure by developing polymer fillers as a new venture. Meta Biomed was established in 1999 and is headquartered in Cheongju, Chungcheongbuk-do.